Tag

Bcg Vaccine

All articles tagged with #bcg vaccine

health1 year ago

Vaccination Reduces Long COVID Risk, Studies Confirm

A phase 3 clinical trial suggests that the BCG vaccine, when administered during active COVID-19 infection, may reduce the risk of developing long COVID symptoms. The study, conducted by researchers at the State University of Campinas in Brazil, found that BCG recipients experienced fewer issues with hearing, sleep, concentration, memory, and vision at 6 and 12 months post-injection compared to those who received a placebo. The study highlights the potential of BCG immunotherapy for treating existing ailments rather than as a preventive measure.

health-and-science1 year ago

"Century-Old Vaccine Unveils Surprising Flu Prevention Power"

Researchers at McGill University Health Centre have discovered that the century-old tuberculosis vaccine, BCG, also provides protection against influenza A, potentially influencing future vaccine development and offering broader virus defense, including against COVID-19. The study, published in Nature Immunology, revealed a previously unknown mechanism that extends the vaccine's shield to combat the most prevalent flu strain, paving the way for further research on its potential to prevent other emergent viruses.

health1 year ago

"Exploring the Potential of a Century-Old TB Vaccine in Preventing Dementia"

Two studies published in the Journal of Alzheimer’s Disease suggest that the 100-year-old BCG vaccine, originally developed to combat tuberculosis, may reduce the risk of developing dementia, including Alzheimer's disease. Research indicates that BCG, known for its use in treating bladder cancer and other conditions, may have immunoprotective effects against dementia, possibly due to its impact on infections. The affordability and potential preventive benefits of BCG and other vaccines raise questions about the focus on expensive anti-amyloid drugs in Alzheimer's research.

health1 year ago

"Repurposing a Century-Old TB Vaccine to Combat Alzheimer's"

The 100-year-old BCG vaccine, originally developed to combat tuberculosis, is now being investigated for its potential to protect against Alzheimer's disease. Studies suggest that the vaccine may enhance the immune system's ability to clear amyloid beta proteins, which are associated with Alzheimer's. While preliminary results are promising, further clinical trials are needed to confirm the vaccine's effectiveness in preventing dementia. If proven successful, the BCG vaccine could offer a cost-effective and accessible solution to combat Alzheimer's disease.

health1 year ago

"Rising TB Cases Prompt Health Experts to Urge GP Consultation"

Health officials in England are investigating the 11% rise in tuberculosis (TB) cases in 2023 compared to 2022, with 4,850 cases reported last year, higher than pre-pandemic levels. The increase has been observed in urban centers as well as regions with low TB incidence. The UK Health Security Agency has launched an investigation to understand the reasons behind this surge and is urging people with persistent coughs lasting longer than three weeks to consult their GPs, as TB can be serious if not addressed.

health2 years ago

"BCG Vaccine Shows Promise in Preventing Alzheimer's"

A recent study suggests that the BCG vaccine, typically used to prevent tuberculosis, may also reduce the risk of Alzheimer’s disease and related dementias. The study followed 6,467 individuals, over 15 years post their diagnosis with non-muscle-invasive bladder cancer. Findings revealed patients who received the BCG vaccine had a 20% lower risk of Alzheimer’s disease and related dementias, and a 25% reduced risk of death. The team is now focusing on exploring the benefits of BCG vaccination in Alzheimer’s disease-related clinical trials.

health2 years ago

Mixed Results for Vaccines in the Fight Against COVID-19

The BRACE trial investigating the efficacy of the BCG vaccine against COVID-19 found that it does not reduce the risk of healthcare workers contracting the disease. The trial involved almost 7000 healthcare workers across 36 sites in five countries. The vaccine was originally developed to prevent tuberculosis and is still given to over 130 million babies worldwide each year for that purpose. The trial team is also using blood samples collected from participants to discover biomarkers for COVID-19 risk and the effect of the vaccine on other infections.